Baxter International Inc. (LON: 0QK8)
Market Cap | 13.20B |
Revenue (ttm) | 11.24B |
Net Income (ttm) | 80.58M |
Shares Out | n/a |
EPS (ttm) | 0.16 |
PE Ratio | 163.76 |
Forward PE | n/a |
Dividend | 0.81 (2.55%) |
Ex-Dividend Date | Nov 29, 2024 |
Volume | 2,969 |
Average Volume | 4,452 |
Open | 31.50 |
Previous Close | 31.23 |
Day's Range | 31.12 - 32.23 |
52-Week Range | 31.02 - 50.11 |
Beta | n/a |
RSI | 60.23 |
Earnings Date | Feb 6, 2025 |
About Baxter International
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technol... [Read more]
News
Protesters get the hump in hospital beds demo
Demonstrators are joined by Baxter the camel, in a call for in-patient beds at Ellen Badger Hospital.
How Is The Market Feeling About Baxter Intl?
Baxter Intl's (NYSE: BAX) short percent of float has fallen 3.35% since its last report. The company recently reported that it has 12.37 million shares sold short , which is 3.17% of all regular shar...
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Jo...
Baxter International Inc (BAX) Expands U.S. ...
Baxter International Inc (BAX) Expands U.S. Pharmaceuticals Portfolio with Five New Injectable Launches
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product laun...
Baxter restarts dialysis solutions production at North Cove plant
Baxter International (BAX) said it has re-started all of its peritoneal dialysis solutions manufacturing lines at its North Cove, N.C., plant. Read more here.
Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.
Baxter to Present at 7th Annual Evercore HealthCONx Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade...
Baxter to Present at Jefferies London Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade,...
Baxter to Present at Stifel 2024 Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter'...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Al...
Baxter cuts annual profit forecast on hurricane impact
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.
Baxter Reports Third-Quarter 2024 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the thi...
Baxter restarts IV solutions manufacturing line
Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related fl...
Oneview Healthcare and Baxter International Extend Value-Added Reseller Agreement for Two More Years and Expand the Agreement to include Canada
DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an...
Baxter expects to restart IV solutions manufacturing line within next week
Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at a hurricane-hit plant in North Carolina within the next week.
Baxter to Present at UBS Global Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxte...
Baxter aims to restore new dialysis patient access to pre-hurricane levels by year-end
Baxter International on Monday said that it aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.
Baxter to import 18,000 tons of IV products to US by year-end
Baxter International said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the end of the year to mitigate a shortage caused by...
Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, ...
Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore
The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition o...
Baxter International (BAX) Reports Impact of Hurricane Helene on North Cove Facility
Baxter International Inc. (BAX, Financial), a leading healthcare company, has issued a press release detailing the impact of Hurricane Helene on its North Cove facility located in Marion, North Caroli...
Does Baxter Stock Offer Any Room For Growth?
Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson...
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina
Baxter International Inc BAX. has shut down its largest manufacturing facility following significant damage caused by Hurricane Helene.